Vancouver, Canada

Stefanie Zentelis

USPTO Granted Patents = 3 

Average Co-Inventor Count = 24.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
3 patents (USPTO):

Title: Stefanie Zentelis: Innovator in Anti-Coronavirus Antibodies

Introduction

Stefanie Zentelis is a prominent inventor based in Vancouver, Canada. She has made significant contributions to the field of biotechnology, particularly in the development of antibodies for combating coronavirus-related diseases. With a total of 3 patents, her work is crucial in the ongoing fight against viral infections.

Latest Patents

Among her latest patents are innovative antibodies that specifically bind to the spike proteins of SARS-CoV and SARS-CoV-2. These antibodies are designed for use in treating or preventing conditions associated with SARS or COVID-19. Additionally, they serve as tools for detecting the presence of these viruses, showcasing her commitment to advancing medical science and public health.

Career Highlights

Stefanie has worked with esteemed organizations such as the National Institutes of Health, a component of the US Department of Health & Human Services, and Abcellera Biologics Inc. Her experience in these institutions has allowed her to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Throughout her career, Stefanie has collaborated with talented individuals, including Kathryn Westendorf and Krithika Muthuraman. These partnerships have enhanced her research and expanded the impact of her innovations.

Conclusion

Stefanie Zentelis is a trailblazer in the field of biotechnology, particularly in the development of anti-coronavirus antibodies. Her innovative work and collaborations are vital in addressing global health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…